Guselkumab Immunogenetics

Clinical trial NCT04645355 · COMPLETED

Trial details

NCT number: NCT04645355
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Guttate Plaque Psoriasis

Start date: 2021-03-01
Primary completion: 2025-04-04
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.